4Dmedical (ASX: 4DX) — Perfil da empresa, notícias e dados financeiros
4DMedical is a global medical technology company revolutionizing lung function analysis for respiratory disease with patented technology.
4Dmedical
4Dmedical is a medical technology company focused on global respiratory healthcare through advanced lung imaging software and hardware solutions. The company's core four-dimensional lung imaging technology converts standard X-ray fluoroscopy and CT scans into quantitative, spatially detailed analyses of regional lung ventilation and airflow dynamics. Its product portfolio includes software solutions such as XV LVAS, CT:VQ, and specialized analytical tools for detecting conditions like chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and pulmonary hypertension. Operating across clinical care, clinical trials, and veterans' health facilities, 4Dmedical provides non-invasive diagnostic capabilities to healthcare providers, research institutions, and hospitals worldwide.
Resumo
Operações
Produtos e/ou serviços de 4Dmedical
- XV LVAS Software: FDA-cleared software that processes standard fluoroscopic X-ray images to generate quantitative, four-dimensional regional ventilation maps, measuring localized airflow throughout the lungs during full breathing cycles for clinical assessment of respiratory conditions.
- CT VQ Imaging Software: Diagnostic software platform that calculates quantitative ventilation and perfusion metrics from non-contrast CT scans, offering non-invasive, contrast-free evaluation of pulmonary vascular and airflow distribution across lung tissue in clinical diagnostic workflows.
- XV Scanner Hardware: Dedicated hardware scanner designed to perform low-dose, rapid four-dimensional lung imaging, integrating proprietary motion-analysis software with specialized hardware to capture detailed dynamic respiratory function data in clinical and research environments.
- Specialized CT Analytics: Suite of analytical software modules including Lung Density Analysis, Lung Texture Analysis, and Pulmonary Hypertension Assessment that quantify tissue density variations and structural lung changes for idiopathic pulmonary fibrosis and vascular monitoring.
- Veterans Healthcare Programs: Diagnostic screening and clinical care integration services provided to healthcare networks including the United States Department of Veterans Affairs, assessing respiratory conditions and toxic airborne exposure in veteran populations using quantitative imaging analysis.
- Clinical Research Services: Contract research services and customized analytical imaging tools provided to pharmaceutical companies, academic institutions, and clinical trial sponsors to assess drug efficacy, respiratory treatment outcomes, and therapeutic trial endpoints across study cohorts.
equipe executiva do 4Dmedical
- Andreas FourasFounder, MD, CEO & Director
- Julian SuttonCFO & Executive Director
- Matt TuckerChief Commercial Officer
- Beth PlunkettGeneral Counsel
- Aidan JamisonSenior Vice President of Engineering
- Rachael TenkatenSenior Vice President of Product
- Greg T. MogelChief Medical Officer
- David HannesSenior Vice President of Global Business Development
- Hamish GeorgeCompany Secretary
Últimas notícias sobre a 4Dmedical
4DMedical annual scan volume increases by 77%
Australia4DMedical reports full year revenue of $7.2M
AustraliaUS bill proposes US$20M for 4DMedical
AustraliaWhy medical imaging innovators are racing for regulatory clearance
Australia4DMedical secures regulatory approval in sixth market
Australia4DMedical targets US$2.5B pulmonary embolism market
Australia
Comunicados recentes
O que a 4Dmedical (4DX) comunicou ao mercado, do mais recente para o mais antigo.
- Notification of cessation of securities - 4DX
- Application for quotation of securities - 4DX
- Becoming a substantial holder
- Change in substantial holding
Principais indicadores financeiros
Resultados divulgados pela 4Dmedical, em AUD.
- Cap. de mercado
- 1,4 bi
- Receita (TTM)
- 7,1 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.4
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 7,1 mi | -57,5 mi | -204,4 mi | |
| 5,9 mi | -47,5 mi | -30,1 mi | |
| 3,8 mi | -28 mi | -36 mi | |
| 718,6 mil | -30,7 mi | -31,5 mi |